Protection of cardiac cell-to-cell coupling attenuate myocardial remodeling and proarrhythmia induced by hypertension

T Egan Benova1, B Szeiffova Bacova, C Viczenczova

  • 1Institute for Heart Research, Slovak Academy of Sciences, Bratislava, Slovakia. tamara.benova@savba.sk.

Physiological Research
|September 20, 2016
PubMed

Insights

Hypertension can cause heart problems by affecting connexin-43 channels. Certain supplements like melatonin and omega-3 fatty acids may protect the heart by improving connexin-43 function and preventing arrhythmias.

Area of Science:

  • Cardiovascular Science
  • Molecular Cardiology

Background:

  • Gap junction connexin channels, particularly connexin-43, are vital for myocardial conduction and synchronized heart function.
  • Hypertension is a major risk factor for cardiovascular events, including heart attack, heart failure, stroke, and sudden arrhythmic death.
  • Hypertension-induced myocardial remodeling can lead to connexin-43 mislocalization and dysfunction, contributing to arrhythmias and heart failure.

Purpose of the Study:

  • To investigate the role of connexin-43 abnormalities in hypertension-related cardiac dysfunction.
  • To explore the cardioprotective and antiarrhythmic effects of non-pharmacological compounds in the context of hypertension.

Main Methods:

  • Review of recent studies on connexin-43 in hypertension.
  • Analysis of the impact of compounds like melatonin, omega-3 fatty acids, and red palm oil on myocardial connexin-43 and cardiac function in hypertensive models.

Main Results:

  • Down-regulation, abnormal distribution, and altered phosphorylation of myocardial connexin-43 are implicated in hypertension-induced cardiac issues.
  • Supplementation with melatonin, omega-3 fatty acids, and red palm oil demonstrated cardioprotective effects in hypertensive animals.
  • These compounds attenuated connexin-43 abnormalities, preserved myocardial architecture, and improved cardiac conduction, leading to protection from lethal arrhythmias.

Conclusions:

  • Novel mechanisms for the cardioprotective (antihypertensive and antiarrhythmic) effects of certain compounds have been uncovered.
  • These findings highlight the potential of melatonin, omega-3 fatty acids, and red palm oil in managing hypertension-related cardiac complications.
  • Further clinical trials are warranted to assess the antiarrhythmic potential of these compounds in hypertensive patients.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.4K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.4K
Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
2.5K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.2K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
611
Antihypertensive Drugs: Action of β1 Blockers01:17

Antihypertensive Drugs: Action of β1 Blockers

β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
2.2K